English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45023/58199 (77%)
造訪人次 : 2077792      線上人數 : 179
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋


    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6444


    題名: 利用非對稱性膜膠囊以滲透壓方式釋放難溶性藥物之研究
    Asymmetric membrane capsules for the delivery of poorly water soluble drugs by osmotic pressure
    作者: 林盈谷
    Lin Ying-Ku
    貢獻者: 藥學研究所
    關鍵詞: 非對稱性膜膠囊
    滲透壓
    難溶性藥物
    Asymmetric membrane capsules
    osmotic pressure
    poorly water soluble drugs
    日期: 2002
    上傳時間: 2009-09-11 16:55:35 (UTC+8)
    摘要: 對於一個水不會崩散之膠囊系統而言，其膠囊殼具有非對稱性膜之結構，此結構可增加水通透性而增強滲透壓的作用，進而釋放難溶性藥物。膠囊殼是以相轉換的方式所產生，製備過程是先將模具浸入含有聚合物的包覆溶液(coating solution)，再浸入到淬鍊溶液(quenching solution)，而在膜具上形成具有非對稱結構之膠囊殼。此膠囊殼可以充填入不同成份的藥物或賦型劑，成為以滲透壓釋放的控釋劑型。選擇felodipine和 nifedipine 兩種難溶性藥物為模式藥物，研究非對稱性膜膠囊以滲透壓作用釋放難溶藥物的情形。
    結果顯示藥物從非對稱性膜膠囊的釋放會因藥物的溶解度增加而增加，藥物的溶出速率與藥物溶解度成線性相關。為了增加難溶藥物的釋出，配方中添加了助溶劑。在nifedipine的滲透劑型中，影響膠囊內處方的因子包括hydroxypropyl methylcellulose (HPMC)的黏度和添加量、sodium lauryl sulfate (SLS)的添加量和nifedipine的含量將被探討測試。實驗結果發現HPMC 50cps在處方中是一個適當的增稠劑，HPMC和SLS的添加都會增加藥物的釋出，而藥物的含量並不影響藥物的釋出。在本實驗中nifedipine由此滲透膠囊劑型釋放的機制亦將一併討論。
    A non-disintegrating polymeric capsule system, in which asymmetric membrane offers an improved osmotic pump effect, was used to release poorly water-soluble drug in a control manner after encapsulation. The capsule wall was made by a phase inversion process, in which asymmetric membrane was formed on stainless steel mold pins by dipping the mold pins into a coating solution containing a polymeric material followed by dipping into a quenching solution. The polymeric capsule with asymmetric membrane is then filled with a blend of the active agent and excipient for the controlled drug delivery modulated by osmotic pump effect. Two poorly water-soluble drugs of felodipine and nifedipine were selected as the model to demonstrate that the controlled release characteristics can be manipulated by the design of polymeric capsule with coating an asymmetric membrane.
    The results showed that the release rate from asymmetric membrane capsule increased with increasing solubility for both drugs. A correlation between drug solubility and the initial drug release rate (calculated from the slope of the drug release profile) was verified to be linear. In order to enhance the release rate for these two poorly water-soluble drugs, solubilization with the addition of solubility enhancers is necessary. In the osmotic system for nifedipine, the influence of core formulation variables including viscosity and amount of hydroxypropyl methylcellulose (HPMC), amount of sodium lauryl sulfate (SLS), and nifedipine loadings were examined. It was found that HPMC 50cps was suitable to be a thickening agent and both amount of HPMC and SLS showed a comparable and profoundly positive effect, whereas nifedipine loading had no influence on the drug release rate. Mechanism responsible for the controlled release of nifedipine from this system was proposed.
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc26KbMicrosoft Word107檢視/開啟
    摘要.pdf60KbAdobe PDF211檢視/開啟
    摘要.ppt112KbMicrosoft Powerpoint118檢視/開啟
    摘要.ps339KbPostscript76檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice

    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋